These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 368088)

  • 21. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transient anti-hypertensive effect of phentolamine in patients receiving beta-blocker treatment.
    Dawson A; Smith I; Johnson BF
    J Int Med Res; 1977; 5(6):462-4. PubMed ID: 338396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients.
    van Herwaarden CL; Fennis JF; van 'T Laar A
    Neth J Med; 1979; 22(1):17-22. PubMed ID: 368667
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.
    Vandenburg MJ
    Br J Clin Pharmacol; 1982 Nov; 14(5):733-7. PubMed ID: 7138753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
    Grüninger U; Akert R; Hunkeler H; Wegmüller E; Weidmann P; Hodler J
    Klin Wochenschr; 1979 Jul; 57(14):731-9. PubMed ID: 470335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
    Schlesinger Z; Ravid M; Meshulam R
    Cardiology; 1983; 70(4):199-205. PubMed ID: 6357438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and tolerability of long term oxprenolol and chlorthalidone singly and in combination in hypertensive blacks.
    Obel AO
    Jpn Heart J; 1990 Mar; 31(2):183-92. PubMed ID: 2192098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
    Rackensperger W; Gaupp R; Mattke DJ; Schwarz D; Stutte KH
    Arch Psychiatr Nervenkr (1970); 1974 Jun; 219(1):29-36. PubMed ID: 4152285
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the antihypertensive effect of propranolol and oxprenolol in man].
    Gilfrich HJ; Nicolescu RF; Rahn KH; Willems D
    Verh Dtsch Ges Inn Med; 1971; 77():934-7. PubMed ID: 5156090
    [No Abstract]   [Full Text] [Related]  

  • 36. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 37. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
    Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
    Obel AO
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
    Vlachakis ND
    J Clin Pharmacol; 1980 Jan; 20(1):20-9. PubMed ID: 6987282
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.